Activation of alternative pathways of angiogenesis and involvement of stem cells following anti-angiogenesis treatment in glioma.
about
Small molecule R1498 as a well-tolerated and orally active kinase inhibitor for hepatocellular carcinoma and gastric cancer treatment via targeting angiogenesis and mitosis pathwaysSunitinib added to FOLFIRI versus FOLFIRI in patients with chemorefractory advanced adenocarcinoma of the stomach or lower esophagus: a randomized, placebo-controlled phase II AIO trial with serum biomarker program.Imaging biomarkers for antiangiogenic therapy in malignant gliomas.Clinical response to sunitinib as a multitargeted tyrosine-kinase inhibitor (TKI) in solid cancers: a review of clinical trials.The challenges and the promise of molecular targeted therapy in malignant gliomas.Bone marrow derived myeloid cells orchestrate antiangiogenic resistance in glioblastoma through coordinated molecular networks.Combination of vatalanib and a 20-HETE synthesis inhibitor results in decreased tumor growth in an animal model of human glioma.The combination of novel targeted molecular agents and radiation in the treatment of pediatric gliomas.Effect of melatonin on tumor growth and angiogenesis in xenograft model of breast cancer.p53 Mutation: Critical Mediator of Therapy Resistance against Tumor Microenvironment.Anti-VEGFR2 driven nuclear translocation of VEGFR2 and acquired malignant hallmarks are mutation dependent in glioblastoma.Kelussia odoratissima Mozaff. activates intrinsic pathway of apoptosis in breast cancer cells associated with S phase cell cycle arrest via involvement of p21/p27 in vitro and in vivo.Cord blood endothelial progenitor cells as therapeutic and imaging probes.Chimeric Mouse model to track the migration of bone marrow derived cells in glioblastoma following anti-angiogenic treatments.Changes in vitreous VEGF, bFGF and fibrosis in proliferative diabetic retinopathy after intravitreal bevacizumab.Neovascularization in Glioblastoma: Current Pitfall in Anti-angiogenic therapy.Cancer-associated fibroblasts support vascular growth through mechanical force.Major Challenges and Potential Microenvironment-Targeted Therapies in Glioblastoma.Translational gap in ongoing clinical trials for glioma.
P2860
Q27317155-BE0E2B2B-6620-41CF-99F7-DF667AB72EE8Q30313895-3A1FBD03-E158-41E2-8FF1-3A7B7756DEB8Q30764736-85956763-6BF8-4A17-AB87-C94FA729F1F8Q33633431-B61CFFB4-685D-4AA5-B2CE-3433B8579298Q35214534-33FF4520-FD94-467F-AAD2-3B21D9E1B8F7Q36390700-38D0E1C9-BAB2-4DB3-8D27-B07936EDEC5EQ36684023-8BF68539-9B9A-490C-9618-C89C0E526D07Q36833480-6D32CE5D-673E-467E-BA4A-7F6B7843F051Q37458674-D78CB3BC-B211-460B-A1CF-1745449989B9Q37468744-8098DE62-ABEF-4D4D-9EFE-41D5AA22B9ABQ37613594-DCC43B29-FEB3-4B92-B253-A0D496394F80Q37626468-B0147464-CEFC-44D0-A508-64E20CDBED63Q38066215-575C64CF-BED7-45E0-B025-DA166D34943BQ38800593-0E9B59E6-4936-4D23-8621-83651AA4CEB2Q40196662-7BE99FF2-0FD3-4D65-A462-8A54B244CEF8Q41383985-EB96E292-4294-428D-8606-260FE693CA3AQ42282668-2FFFE2E8-21AB-42E0-888E-034C3F523465Q47773621-3AA5C80B-84AE-4D54-AC96-AB0637D55822Q48002716-4FE33A29-9D82-4E7D-8679-7BA5433F9B8F
P2860
Activation of alternative pathways of angiogenesis and involvement of stem cells following anti-angiogenesis treatment in glioma.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Activation of alternative path ...... iogenesis treatment in glioma.
@en
Activation of alternative path ...... iogenesis treatment in glioma.
@nl
type
label
Activation of alternative path ...... iogenesis treatment in glioma.
@en
Activation of alternative path ...... iogenesis treatment in glioma.
@nl
prefLabel
Activation of alternative path ...... iogenesis treatment in glioma.
@en
Activation of alternative path ...... iogenesis treatment in glioma.
@nl
P2860
P356
P1476
Activation of alternative path ...... iogenesis treatment in glioma.
@en
P2093
Ali S Arbab
P2860
P304
P356
10.14670/HH-27.549
P577
2012-05-01T00:00:00Z